SeaCrest Wealth Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $251K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $614K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $423K | Sell |
|
|||||
|
2022
Q2 | $590K | Sell |
|
|||||
|
2022
Q1 | $637K | Sell |
|
|||||
|
2021
Q4 | $559K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $200K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $45K | Sell |
|
|||||
|
2018
Q4 | $118K | Sell |
|
|||||
|
2018
Q3 | $575K | Sell |
|
|||||
|
2018
Q2 | $510K | Sell |
|
|||||
|
2018
Q1 | $615K | Buy |
|
|||||
|
2017
Q4 | $420K | Buy |
|